Your session is about to expire
← Back to Search
Device
Bodyport Scale for Heart Failure (SCALE-HF 1 Trial)
N/A
Waitlist Available
Led By Adam Devore, MD
Research Sponsored by Bodyport Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Provide informed consent before trial enrollment
Age ≥ 18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 1 year
Awards & highlights
SCALE-HF 1 Trial Summary
This trial will use the Bodyport Scale to see if it can help detect early signs of worsening heart failure.
SCALE-HF 1 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSCALE-HF 1 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ approximately 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of Worsening HF Events as measured by patient report
Secondary outcome measures
Number of patients that had an urgent care visit with the primary diagnosis of HF as measured by medical record abstraction.
SCALE-HF 1 Trial Design
1Treatment groups
Experimental Treatment
Group I: Bodyport ScaleExperimental Treatment1 Intervention
All subjects will be given the Bodyport scale to use
Find a Location
Who is running the clinical trial?
Bodyport Inc.Lead Sponsor
1 Previous Clinical Trials
712 Total Patients Enrolled
Duke Clinical Research InstituteOTHER
62 Previous Clinical Trials
240,232 Total Patients Enrolled
7 Trials studying Heart Failure
16,840 Patients Enrolled for Heart Failure
Adam Devore, MDPrincipal InvestigatorDuke Clinical Research Institute
1 Previous Clinical Trials
120 Total Patients Enrolled
1 Trials studying Heart Failure
120 Patients Enrolled for Heart Failure
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How extensively is this exploration being conducted across the United States?
"For this medical trial, there are 8 active sites including Self Regional Healthcare Research Center in Hodges, Cardiovascular Institute of Northwest Florida in Panama City and RecioMed Clinical Research Network Inc. located in Boynton Beach."
Answered by AI
Is recruitment currently taking place for this clinical experiment?
"Per the information posted on clinicaltrials.gov, this particular experiment is no longer taking enrollees. The trial was first listed in 8th July 2021 before concluding on 19th July 2022 with 701 other studies actively searching for volunteers at present time."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger